FDA Inspection
American National Red Cross (the)American National Red Cross (the) – FDA Inspection, Sep 13, 2013
Record Details
This FDA Inspection record concerns American National Red Cross (the), with an inspection on September 13, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 13, 2013
- Product Type
- Biologics
View Company Profile
ID · 34a8465c-85c3-462f-816e-c403e8c96649
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 848041
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.40Clean & orderly
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American National Red Cross (the)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 13, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 13, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross (the)
- FDA Inspection 1229683 - 2024-08-01
- FDA Inspection 1108974 - 2019-09-13
- FDA Inspection 991521 - 2016-10-20
- FDA Inspection 803205 - 2012-10-16
- FDA Inspection 695271 - 2010-10-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.